Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2003
07/03/2003CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003CA2470938A1 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
07/03/2003CA2469278A1 Isochroman compounds for treatment of cns disorders
07/03/2003CA2469042A1 Triazoles as oxytocin antagonists
07/03/2003CA2436850A1 Protease inhibitors
07/02/2003EP1323716A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
07/02/2003EP1323710A1 Nitrogenous five-membered ring compounds
07/02/2003EP1322650A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
07/02/2003EP1322645A2 Quinazolines, medicaments, which contain these compounds and which are effective as tyrosine kinase inhibitors, their use, and methods for the production thereof
07/02/2003EP1322644A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
07/02/2003EP1322643A1 Piperazin-2-one amides as inhibitors of factor xa
07/02/2003EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives
07/02/2003EP1322635A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
07/02/2003EP1322622A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
07/02/2003EP1322621A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
07/02/2003EP1322617A1 Compounds and methods for modulation of estrogen receptors
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322611A1 Chemical compounds
07/02/2003EP1322608A1 Delta1-pyrrolines used as pesticides
07/02/2003EP1322599A2 Hiv integrase inhibitors
07/02/2003EP1322309A2 High affinity small molecule c5a receptor modulators
07/02/2003EP1322302A2 Taxoid conjugates as antimitotic and antitumor agents
07/02/2003EP1322298A1 Pharmaceutical oxan preparation
07/02/2003EP1224180B1 Substituted azoles
07/02/2003EP1070041B1 Phosphate-mediated cyclization
07/02/2003EP0990655B1 Method for drying anhydrous paroxetine hydrochloride
07/02/2003EP0900211B1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
07/02/2003EP0841916B1 Endothelin receptor antagonists
07/02/2003EP0779810B1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes
07/02/2003EP0740658B1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics
07/02/2003CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments
07/02/2003CN1427828A Substituted N-benzoyl-N'-(tetrazolylphenyl)-ureas and their use as pest control agents
07/02/2003CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
07/02/2003CN1427824A Indole derivatives, process for preparation of same and use thereof
07/02/2003CN1427823A Pyrrolecarboxamides and pyrrolethioamides as fungicides
07/02/2003CN1113059C Pipeazino derivatives as neurokinin antagonists
07/02/2003CN1112927C Pharmaceutical composition of corpus albicans emulsifier type lipophilic compound
07/02/2003CN1112848C Pest controlling agent containing substituted aminoquinazolone or thioketone derivative or its salt as active component
07/01/2003US6586606 Process for the preparation of 3-aryl-benzofuran-2-ones
07/01/2003US6586603 Forming 4-(5-(4-chlorophenyl)-3-trifluoromethyl)-1H-pyrazol-1 -yl)benzenesulfonamide used as antiinflammatory agents; side effect reduction
07/01/2003US6586466 Carbohydrazide-protease inhibitors
07/01/2003US6586454 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
07/01/2003US6586442 Benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
07/01/2003US6586441 Adenosine receptor ligands and their use in the treatment of disease
07/01/2003US6586436 Serotonergic agents
07/01/2003US6586435 Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
07/01/2003US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders
07/01/2003US6586368 Condensed heterocylic compounds and herbicides containing them
06/2003
06/26/2003WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
06/26/2003WO2003051868A1 Lactams as tachykinin antagonists
06/26/2003WO2003051866A1 2-guanidino-4-heterocyclylquinazolines
06/26/2003WO2003051860A2 Substituted 2-phenyl benzofurans as estrogenic agents
06/26/2003WO2003051847A1 (1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
06/26/2003WO2003051846A2 Substituted phenyl derivatives
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051360A1 Cis-imidazolines as mdm2 inhibitors
06/26/2003WO2003051359A1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors
06/26/2003WO2003051358A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003WO2003051354A1 Method of treatment
06/26/2003WO2003051306A2 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
06/26/2003WO2003051277A2 Novel compounds
06/26/2003WO2003051276A2 Therapeutic heterocycles
06/26/2003WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003WO2003040109A3 Quinazoline derivatives as antitumor agents
06/26/2003US20030120080 Such as (2S)-2-((4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl) butanamide; antiepileptic agents; anticonvulsants
06/26/2003US20030120079 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction
06/26/2003US20030120072 Such as (4-(3,4-Difluoro-phenyl)-piperazin-1-yl)-((4S ,4aS,8aR)-2-((S)-3-(6-methoxy-pyridin-3-yl)-2-methyl-propyl)-decahydro -isoquinolin-4yl)-methanone for treatment of schizophrenia, depression, anxiety and bipolar disorders
06/26/2003US20030120065 Diagnosis using triplex binding
06/26/2003US20030120064 Processes for preparing beta-D-ribofuranose derivatives
06/26/2003US20030119896 Chondrogenesis promoters and indolin-2-one derivatives
06/26/2003US20030119895 Anticancer agents
06/26/2003US20030119878 A 1-arylalkyl-3-aminoalkyl-1,4-dihydropyrid-4-one derivative; sexual disorders; anticarcinogenic agents; benign prostatic hypertrophy/fibroids of the uterus; endometriosis, polycystic ovarian disease, precocious puberty; contraceptives
06/26/2003US20030119868 Gyrase inhibitors and uses thereof
06/26/2003US20030119857 Pyrimidinyl methyl indole derivatives with antibacterial activity
06/26/2003US20030119856 Thiazole compounds useful as inhibitors of protein kinase
06/26/2003US20030119852 Pyridine or pyrimidine compounds containing C(=O or =S)-N-S(O)m=o,1,2 group, used as insecticides, fungicides, miticides and parasiticides
06/26/2003US20030119845 4-((4-benzyl(or methyl heteroaryl)-,1-piperazinyl)(8-quinolinyl)methyl)-N,N-diethylbenzamide or salt, useful for pain treatment
06/26/2003US20030119844 Bind with high selectivity and/ or high affinity to CRF1 receptors (Corticotropin Releasing Factor 1 Receptors), useful for treating psychiatric and neurological diseases, including depression, anxiety and post trauma stress
06/26/2003US20030119836 Cyclooxygenase inhibitors
06/26/2003US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/26/2003US20030119834 Angiogenesis inhibitors; 3-alkyl-4-one quinazoline derivatives
06/26/2003US20030119830 Monocyte chemoattractant protein-1 inhibitor compounds
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119816 Cycline-dependent kinase protein inhibitors; antiproliferative agents
06/26/2003US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke.
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119754 Treating respiratory syncytial virus and human parainfluenza virus infections
06/26/2003US20030119753 Novel ascorbic acid compounds, methods of synthesis and application use thereof
06/26/2003US20030119670 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof
06/26/2003US20030115684 Couplers for oxidative hair dyes
06/26/2003CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives
06/26/2003CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003CA2470352A1 Substituted 2-phenyl benzofurans as estrogenic agents
06/26/2003CA2470276A1 Substituted phenyl derivatives
06/26/2003CA2470236A1 Lactams as tachykinin antagonists
06/26/2003CA2470214A1 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
06/26/2003CA2470030A1 2-guanidino-4-heterocyclylquinazolines
06/26/2003CA2468978A1 Therapeutic heterocycles
06/26/2003CA2468783A1 Cis-imidazolines as mdm2 inhibitors
1 ... 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 ... 694